PCSA
Processa Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.03M
P/E Ratio
—
EPS
$-10.36
Beta
0.89
52W High
$19.62
52W Low
$1.76
50-Day MA
$2.57
200-Day MA
$5.05
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Processa Pharmaceuticals Inc
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients with unmet medical needs in the United States. The company is headquartered in Hanover, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-13.99M |
| Operating Margin | 0.00% |
| Return on Equity | -373.00% |
| Return on Assets | -158.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.17 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | 1320.06 |
| EV/Revenue | 68.28 |
| EV/EBITDA | -0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.66M |
| Float | $2.43M |
| % Insiders | 12.60% |
| % Institutions | 8.31% |
Data last updated: 4/9/2026